GlassScriptPhysician profile
Stephen C Kwasniewski
NPI 1639265408
$556.28
in general payments reported to CMS, 2019-2025
15 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.55 · 2022: $16.45 · 2023: $184 · 2024: $123 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $258.63 | 2023-2025 | Na, Va-Lcp, Motoband |
| Radius Health, INC. | $44.65 | 2024-2025 | Tymlos |
| Si-Bone, INC. | $31.91 | 2023 | |
| Heraeus Medical, LLC. | $30.84 | 2023 | Palacos |
| Nalu Medical, INC. | $27.07 | 2025 | Nalu Neurostimulation System |
| Foundation Fusion Solutions, LLC | $21.66 | 2024 | |
| Spr Therapeutics, INC | $19.13 | 2025 | Sprint Pns System |
| International Rehabilitative Sciences, INC | $17.60 | 2024 | Rs 4i Plus Sequential Stimulator |
| Pacira Pharmaceuticals Incorporated | $16.97 | 2024 | Zilretta, Exparel, Iovera |
| Avanos Medical | $16.45 | 2022 | |
| Smith+Nephew, INC. | $15.88 | 2024 | Stravix Pl, Stravix Mesh, Grafix Pl |
| Vertex Pharmaceuticals Incorporated | $15.85 | 2024 | |
| Pacira Therapeutics, INC. | $14.60 | 2021 | |
| Endo USA, INC. | $13.09 | 2024 | Xiaflex |
| Sanofi-Aventis U.S. LLC | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Kwasniewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.